Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Wei-Ran LiuBin ZhangChen ChenYue LiXin YeDong-Jiang TangJun-Cheng ZhangJing MaYan-Ling ZhouXian-Jun FanDong-Sheng YueChen-Guang LiHua ZhangYu-Chen MaYan-Song HuoZhen-Fa ZhangShu-Yu HeChang-Li WangPublished in: Thoracic cancer (2020)
What this study adds: This study aimed to evaluate the potential clinical application of the CAC test for the early diagnosis of NSCLC. Significant findings of the study: CAC detection in early stage NSCLC was feasible. Our study showed that CACs could be used as a promising noninvasive biomarker for the early diagnosis of NSCLC.